CMS certification 310001
Hackensack University Medical Center
30 Prospect Ave, Hackensack, NJ 07601
Hackensack University Medical Center has a CMS overall rating of 5 out of 5 stars. 74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 12 and worse on 4. Emergency patients spend a median of 3 h 22 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 4,034 completed surveys, 16% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NJ | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 382 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 22 min | 3 h 6 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 13 visits sampled | 4 h 9 min | 4 h 52 min | 4 h 17 min |
| Left before being seen Lower is better · 150,754 patients | 1% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 14 patients | 93% | 73% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 204 patients | 72% | 73% | 65% |
How Hackensack University Medical Center compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Hackensack University Medical CenterThis hospital | 5/5 | 74% | 3 h 22 min | 12 better 4 worse |
| Englewood Hospital and Medical CenterSame county · Englewood | 4/5 | 78% | 3 h 3 min | 3 better 2 worse |
| Bergen New Bridge Medical CenterSame county · Paramus | Not rated | 65% | 2 h 25 min | 1 better 1 worse |
| Valley HospitalSame county · Paramus | 4/5 | 79% | 3 h 47 min | 6 better 1 worse |
| Holy Name Medical CenterSame county · Teaneck | 5/5 | 73% | 3 h 24 min | 4 better 1 worse |
| Hackensack Meridian Health Pascack Valley MedicalSame county · Westwood | 5/5 | 70% | 2 h 22 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,455 cases | Too few cases | 2.9% | 3.9% |
| Heart attack 319 cases | Too few cases | 10% | 11.9% |
| Heart failure 981 cases | Too few cases | 8.2% | 11.1% |
| Pneumonia 1,211 cases | Too few cases | 11% | 15.2% |
| Stroke 579 cases | Too few cases | 9.4% | 11.9% |
| COPD 233 cases | Too few cases | 5.6% | 8.6% |
| Heart bypass surgery (CABG) 258 cases | Too few cases | 1.3% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Better | 0.72 likely 0.54 – 0.91 | 1 |
| After hip or knee replacement 44 cases | Too few cases | 5% | 4.1% |
| Deaths after a serious but treatable surgical complication 238 cases | No different | 163.25 per 1,000 likely 128.74 per 1,000 – 197.77 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 15,623 cases | No different | 0.58 per 1,000 likely 0.24 per 1,000 – 0.93 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 15,346 cases | No different | 0.16 per 1,000 likely 0 per 1,000 – 0.32 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 16,531 cases | No different | 0.22 per 1,000 likely 0.06 per 1,000 – 0.38 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,764 cases | No different | 1.65 per 1,000 likely 0.54 per 1,000 – 2.77 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,630 cases | No different | 1.44 per 1,000 likely 0.27 per 1,000 – 2.61 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,627 cases | Better | 4.88 per 1,000 likely 1.37 per 1,000 – 8.39 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 4,288 cases | No different | 2.13 per 1,000 likely 0.74 per 1,000 – 3.52 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,599 cases | No different | 4.25 per 1,000 likely 1.78 per 1,000 – 6.72 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 1,101 cases | No different | 1.28 per 1,000 likely 0 per 1,000 – 2.58 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 3,345 cases | No different | 0.88 per 1,000 likely 0.14 per 1,000 – 1.62 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.34 likely 0.15 – 0.66 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.38 likely 0.2 – 0.66 | 1 |
| Surgical site infections after colon surgery | No different | 0.51 likely 0.22 – 1.01 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.09 likely 0.35 – 2.62 | 1 |
| MRSA bloodstream infections | No different | 0.8 likely 0.49 – 1.24 | 1 |
| C. diff intestinal infections | Better | 0.35 likely 0.26 – 0.47 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 488 cases | Too few cases | 13.2% | 14.4% |
| Readmitted after heart failure 1,280 cases | Too few cases | 19.9% | 21.3% |
| Readmitted after pneumonia 1,492 cases | Too few cases | 16.1% | 17.3% |
| Readmitted after COPD 293 cases | Too few cases | 19.2% | 20% |
| Readmitted after heart bypass surgery 292 cases | Too few cases | 9.8% | 11% |
| Readmitted after hip or knee replacement 43 cases | Too few cases | 5.2% | 5.8% |
| Days back in hospital after a heart attack 403 cases | Too few cases | 17.3 days per 100 | — |
| Days back in hospital after heart failure 1,092 cases | Too few cases | 16.3 days per 100 | — |
| Days back in hospital after pneumonia 1,244 cases | Too few cases | 8.1 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 706 cases | No different | 12.1 per 1,000 likely 9.3 per 1,000 – 15.7 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 1,195 cases | Worse | 14.3 per 100 likely 12.5 per 100 – 16.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 1,195 cases | Better | 3.6 per 100 likely 2.7 per 100 – 4.6 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 2,075 cases | Better | 0.7 likely 0.5 – 0.8 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
981 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 274 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Emergency Medicine | 93 |
| Anesthesiology | 87 |
| Pediatrics | 79 |
| Physician Assistant | 59 |
| Diagnostic Radiology | 52 |
| Internal Medicine | 49 |
| Family | 48 |
| Adult Health | 34 |
| Hospitalist | 34 |
| Acute Care | 25 |
| Nurse Practitioner | 24 |
| Clinical | 22 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $10.3M
- 2020 $20.2M
- 2021 $16.6M
- 2022 $15.6M
- 2023 $16.1M
- 2024 $14.3M
- 2025 $17.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $415,882 | 6 |
| Speaking, teaching and other services | $170,815 | 36 |
| Medical devices and supplies on long-term loan | $93,402 | 84 |
| Debt forgiveness | $52,019 | 15 |
| Space rental and facility fees | $38,838 | 27 |
| Food and beverage | $350 | 3 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $2.6M | 41 |
| Incyte Corporation | $2.2M | 657 |
| Taiho Oncology, INC. | $1.4M | 105 |
| Daiichi Sankyo Inc. | $1.2M | 751 |
| Merck Sharp & Dohme LLC | $1M | 26 |
| Celgene Corporation | $772,859 | 6 |
| Sanofi US Services INC. | $740,340 | 45 |
| AstraZeneca Pharmaceuticals LP | $540,569 | 13 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Multi-phase, Dose-Escalation Followed by an Open-label, Randomized, Crossover Study of Oral ASTX030 (Cedazuridine and Azacitidine Given in Combinat… TAIHO ONCOLOGY, INC. | $975,439 |
| AC220-168 Daiichi Sankyo Inc. · NCT06578247 | $954,609 |
| A Phase 1/2, Open Label, First-in-human, Dose Escalation and Expansion Study for the Evaluation of Safety, Pharmacokinetics, Pharmacodynamics, and An… SANOFI US SERVICES INC. · NCT05584670 | $735,440 |
| A Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation Incyte Corporation | $734,484 |
| A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors Incyte Corporation | $676,134 |
| A Phase 1b/2, Open-Label Trial to Assess the Safety and Preliminary Efficacy of Epcoritamab (GEN3013; DuoBody-CD3xCD20) in Combination With Other Age… Genmab A/S | $515,402 |
| A phase II study of Iberdomide (CC-220) in combination with Carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed transplant … Celgene Corporation | $427,568 |
| A Phase 1/2a, Multicenter, Open-label, First in Human Study of BMS-986490 with or without Bevacizumab in Advanced Solid Tumors E.R. Squibb & Sons, L.L.C. | $403,069 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Hackensack University Medical Center
Is Hackensack University Medical Center a good hospital?
Hackensack University Medical Center has a CMS overall rating of 5 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 12 and worse on 4. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Hackensack University Medical Center?
74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 4,034 completed HCAHPS surveys.
How long is the wait in the Hackensack University Medical Center emergency room?
Emergency patients spend a median of 3 h 22 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Hackensack University Medical Center receive money from drug and device companies?
Drug and device makers reported $17.1M in payments to Hackensack University Medical Center for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.